Thrombosis and Haemostasis · 2002 · 20 citations · 27 references
MedicineHematologyPediatricsHuman GeneticsMedical GeneticsPediatric HematologyCoagulation DisordersPediatric ThrombosisThromboembolic DiseaseThrombosisThrombotic DisordersVenous ThromboembolismControl Group DesignFactor V MutationInherited Coagulation Factor DeficienciesMatched Control GroupPediatric Coagulation DisordersPediatric Venous ThromboembolismProthrombin G20210a MutationProthrombin Gene Mutation
To determine whether factor V Leiden (FVL) and/or prothrombin gene G20210A mutation (PT20210A) are risk factors for venous thromboembolism (VTE) in Argentinean children. One hundred and thirty consecutive children with VTE were prospectively assisted at a single centre. Blood samples were available from 110 of them for detailed haematological analysis. The prevalence of both mutations was compared with a control group. The odds ratio for VTE was significantly increased in patients with FVL (OR 3.64; 95% CI: 1.14-11.6, p < 0.029) whereas odds ratio for VTE was not significantly increased in patients with PT20210A (OR 1.06; 95% CI: 0.24-4.73, p = 0.938). Combined disorders were found in 5 of the 10 children with the aforementioned mutations. In 21 children (19%) without these mutations other inherited and acquired disorders were detected. Our data show that FVL is a risk factor for VTE whereas PT20210A does not seem to be a risk factor in our paediatric population.
27
Mutation in blood coagulation factor V associated with resistance to activated protein C
Rogier M. Bertina, Bobby P. C. Koeleman, Ted Koster et al. · Nature · 1994 · 3.8K citations
Medicine, Genetics, Hematology +14
John T. Brandt, Douglas A. Triplett, Barbara M. Alving et al. · PubMed · 1995 · 1.2K citations
Medicine, Hematology, Immunology +16
Cerebral Sinovenous Thrombosis in Children
Gabrielle deVeber, Maureen Andrew, Coleen Adams et al. · New England Journal of Medicine · 2001 · 1.1K citations · Full text
Medicine, Child Health, Pediatrics +11